## **Core Concept**
Hyperkalemia refers to an elevated level of potassium ions (K+) in the blood, typically above 5.5 mmol/L. This condition can arise from increased potassium release from cells, decreased potassium excretion by the kidneys, or a combination of both. Understanding the causes of hyperkalemia is crucial for managing patients with electrolyte imbalances.

## **Why the Correct Answer is Right**
The correct answer involves understanding the mechanisms leading to hyperkalemia. Common causes include:
- **Potassium release from cells**: This can occur due to cell lysis (as in hemolysis or tumor lysis syndrome), metabolic acidosis (which shifts potassium out of cells), and certain drugs (like beta-2 agonists or digoxin).
- **Decreased potassium excretion**: This is often related to renal insufficiency or failure, where the kidneys are unable to adequately excrete potassium.
- **Potassium-sparing diuretics** and **ACE inhibitors** can also lead to hyperkalemia by reducing aldosterone levels or antagonizing its effects, thereby decreasing potassium excretion.

## **Why Each Wrong Option is Incorrect**
- **Option A:** [Insert reason why A is incorrect, e.g., "typically causes hypokalemia"].
- **Option B:** [Insert reason why B is incorrect, e.g., "not directly associated with hyperkalemia"].
- **Option C:** [Insert reason why C is incorrect, e.g., "usually leads to a different electrolyte imbalance"].

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **pseudohyperkalemia** can occur due to hemolysis of blood samples, especially if there is significant leukocytosis or thrombocytosis. This artifact can lead to falsely elevated potassium readings. Clinicians should consider this when interpreting lab results, especially in patients with leukemia or lymphoma.

## **Correct Answer:** . **Spironolactone**